GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of August 31, 2026, GRAL trades at $80.00 with a market cap of $3.57B and a P/E ratio of -8.10. GRAL moved -0.91% today. Year to date, GRAL is -7.27%; over the trailing twelve months it is +142.06%. Its 52-week range spans $16.56 to $118.84. Analyst consensus is buy with an average price target of $70.67. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for GRAL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $80.00 |
| Market Cap | $3.57B |
| P/E Ratio | -8.10 |
| EPS | $-9.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $118.84 |
| 52-Week Low | $16.56 |
| Volume | 361.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $165.26M |
| Net Income | $-391.59M |
| Gross Margin | 0.00% |
7 analysts cover GRAL: 0 strong buy, 3 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $70.67.